ByJohn A
A Monthly Budget Checklist for Hers Cost
A usable monthly budget needs five lines, not one: the subscription or consultation fee, the medication charge, lab or monitoring costs where the treatment requires them, shipping, and the renewal date that decides when each of those lands. Hers, the women’s brand of Hims and Hers Health, prices separately by service line, so the total depends entirely on which line is being bought.
Identify the service line before writing down any number
Hers is not a single product. It sells weight management, hair loss treatment, skin care, mental health support, and sexual health, and those lines have genuinely different cost shapes. A topical hair or skin treatment is usually a low, stable charge that stays put for months. A weight program built around an injectable is a charge that moves as the dose moves. A mental health line may carry a provider component priced per visit rather than per month. Carrying a figure across from one line into a budget for another is the most common mistake people make with this brand.
The five lines, and which of them stay still
The subscription or consultation fee buys prescriber access and account administration. It is normally flat, and it is normally charged whether or not a prescription is written, so the question worth asking in advance is what happens to it when a clinician declines to prescribe.
Medication is the largest and the least stable line. Where a program prices by strength, this figure follows the titration schedule rather than the calendar, which means a budget built on the starting strength is a budget built on a temporary number.
Monitoring is a line that many people leave blank. It should not be blank for every treatment. Shipping for temperature-sensitive products is often billed per order, so a plan that ships more frequently can cost more to receive even at the same drug price. The renewal date sits underneath all four, because it fixes the day the charge repeats and, in most subscription models, the last day a change can be made without paying for another cycle.
| Budget line | Flat or variable | What makes it move | Question to settle before the first charge |
|---|---|---|---|
| Subscription or consultation | Flat | Plan term, occasional waivers | Is it charged if no prescription is issued |
| Medication | Variable | Strength, formulation, plan length | What is the price at every strength on the ladder |
| Labs and monitoring | Variable | Drug chosen, baseline results | Bundled, billed separately, or referred out |
| Shipping | Semi-flat | Cold chain, order frequency | Per order or per plan term |
| Renewal date | Fixed | Signup day, prepaid term boundary | What is the cutoff for changing or stopping |
Dose escalation is a scheduled budget event
Injectable weight medications are started low and stepped up on a published schedule. Approved labeling for tirzepatide sets a starting dose held for four weeks before the first increase, and semaglutide labeling follows the same stepped pattern. In a program that prices by strength, that means the monthly figure has a known upward path from the day of signup. The 2025 obesity pharmacotherapy guideline update treats titration to a tolerated maintenance dose as ordinary practice, not an exception, so the maintenance strength rather than the starting strength is the honest basis for a twelve month estimate.
How much of that ladder a program publishes before intake varies widely across this field. Manufacturer self-pay channels such as LillyDirect and NovoCare state terms for their own approved products, while among physician-supervised compounding programs FormBlends publishes medication pricing and plan terms ahead of the consultation. A program that answers the strength question in writing lets the budget be finished before any card is entered.
Monitoring belongs on the sheet for some women’s treatments
Bloodwork is not padding when a label asks for it. Spironolactone, widely prescribed off label for adult acne and for hormonal hair thinning in women, carries labeling that directs prescribers to check serum potassium within one week of starting and regularly after that. The SAFA trial published in the BMJ tested spironolactone for acne in women under exactly that kind of supervised protocol. If a plan includes that drug, the budget needs a monitoring line, and if a plan includes that drug with no monitoring at all, that absence is worth noticing before the price is compared to anything.
Pregnancy planning changes the sheet entirely
This is where a women’s health budget diverges sharply from a men’s. Semaglutide labeling instructs patients taking it for weight reduction to stop at least two months before a planned pregnancy because of the long half-life, and to stop when pregnancy is recognized. Tirzepatide labeling also instructs discontinuation when pregnancy is recognized, and separately advises women on oral contraceptives to switch to a non-oral method or add a barrier method for four weeks after starting and for four weeks after each dose increase. A prepaid multi-month weight plan and an active pregnancy plan do not fit together, and the contraception guidance is itself a small cost line that almost nobody budgets for.
Filling the medication line is easier when more than one provider states its pricing up front, because the budget can be checked against a second column instead of resting on a single quote. The named field here is real: Ro, Hims and Hers, and Henry Meds each structure their weight plans differently, and a provider such as HealthRX lists pricing for GLP-1 medications that drops straight into the sheet. Reading two or three of those side by side is what separates a budget that holds from one built on the cheapest month shown.
Frequently asked questions
Why does one monthly figure not cover everything?
Because the charges arrive on different schedules from different parts of the program. Medication follows the dose ladder, monitoring follows the drug, shipping follows the order, and the subscription follows the signup date. Adding them into a single number only works once each has been priced separately at the strength actually being taken.
Should the budget use the starting dose or the maintenance dose?
The maintenance dose, in any program that prices by strength. Labeling for these injectables sets a stepped increase over the first months of treatment, so the opening figure expires by design. Budgeting at the starting strength produces a number that is accurate for a few weeks and misleading for the rest of the year.
Does compounded medication cost less for a reason?
It costs less partly because it sits outside the approved-product supply chain. A compounded preparation has not been evaluated by the FDA for safety, effectiveness, or manufacturing quality, and the agency has published specific concerns about unapproved versions of these drugs. The price difference and the assurance difference move together.
What is the most useful single number to calculate?
Twelve months at the maintenance strength, plus subscription, monitoring, and shipping, on the plan term actually being purchased. That figure survives comparison against another provider. An introductory month multiplied by twelve does not, and it is the figure most people carry into a budget by accident.
When should the renewal date be checked?
Before the first payment, not after. Subscription models bill on an anniversary, and a change requested a day late usually costs a full extra cycle. Writing the renewal date into the budget alongside the amounts turns cancellation timing from an unpleasant discovery into a diary entry.
Sources
- DailyMed, Zepbound (tirzepatide) prescribing information. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ZEPBOUND
- DailyMed, Wegovy (semaglutide) prescribing information. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=WEGOVY
- DailyMed, spironolactone tablets prescribing information. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=SPIRONOLACTONE
- Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update. https://pubmed.ncbi.nlm.nih.gov/40789597/
- Effectiveness of spironolactone for women with acne vulgaris (SAFA): pragmatic, multicentre, phase 3, double blind, randomised controlled trial. https://pubmed.ncbi.nlm.nih.gov/37192767/
- Glucagon-like Peptide-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications. https://pubmed.ncbi.nlm.nih.gov/40906565/
- FDA, Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- FDA, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
